Director, Value Stream Leader, Spine Digital, MIS and Biomaterials

At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build a aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, and solutions are personal.

Through our expertise in Innovative Medicine and Med Tech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Supply Chain Planning

End-to-End Planning

Professional

Raynham, Massachusetts, United States of America

Johnson & Johnson is recruiting for a Director, Value Stream Leader, Spine Digital, MIS and Biomaterials to sit in Raynham, MA or Zuchwil, Switzerland.

We are seeking a dynamic leader to play a pivotal role in shaping the future of our global supply chain operations. Reporting to the Vice President of Spine, Sports, and CMFT Supply Chain, you will lead the end-to-end supply chain execution of our Spine Biomaterials & Biologics, MIS & Degen, and Enabling Tech business
, driving contemporary best practices in manufacturing and supply chain techniques on a global scale. You will be instrumental in integrating acquired entities into our established framework, ensuring seamless operations and innovation.

Johnson & Johnson announced plans to separate our Orthopaedics business to establish a standalone orthopaedics company, operating as DePuy Synthes. The process of the planned separation is anticipated to be completed within 18 to 24 months, subject to legal requirements, including consultation with works councils and other employee representative bodies, as may be required, regulatory approvals and other customary conditions and approvals.

Should you accept this position, it is anticipated that, following conclusion of the transaction, you would be an employee of DePuy Synthes and your employment would be governed by DePuy Synthes employment processes, programs, policies, and benefit plans. In that case, details of any planned changes would be provided